Physician profile
Pradeep Kumar
NPI 1295838746
$51,350.52
in general payments reported to CMS, 2019-2025
42 companies · $6,458 in 2025
The $6,458 reported for 2025 was more than what 93% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,892 · 2020: $7,335 · 2021: $10K · 2022: $7,795 · 2023: $4,256 · 2024: $6,499 · 2025: $6,458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Food and Beverage: $6,907 · Travel and Lodging: $203 · Education: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,000.00 |
| Food and Beverage | $6,906.98 |
| Travel and Lodging | $203.45 |
| Education | $102.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $36,629.63 | 2019-2025 | Lifevest |
| Medtronic, INC. | $1,677.26 | 2021-2025 | Micra, Venaseal |
| Boston Scientific Corporation | $1,598.13 | 2021-2025 | Watchman Access System, Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $980.90 | 2020-2025 | Farxiga, Atacand, Andexxa |
| Abbott Laboratories | $974.46 | 2020-2025 | Assurity, Jot Dx, Gallant |
| Biotronik INC. | $973.63 | 2019-2025 | Acticor 7 Vr-T Dx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $941.04 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $844.13 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $718.08 | 2019-2023 | Xarelto, Invega Sustenna |
| Amgen INC. | $710.06 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $682.34 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $582.40 | 2019-2025 | Eliquis, Camzyos |
| Bayer Healthcare Pharmaceuticals INC. | $450.67 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $442.01 | 2021-2025 | Verquvo |
| Amarin Pharma, INC. | $438.27 | 2019-2021 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $393.31 | 2020-2025 | Wegovy, Ozempic, Rybelsus |
| Atricure, INC. | $324.87 | 2021-2025 | Atriclip Laa Exclusion System |
| Kestra Medical Technology Services, INC. | $218.24 | 2023-2025 | Assure Wcd |
| Heartflow, INC. | $192.68 | 2023-2025 | Ffrct |
| Regeneron Healthcare Solutions, INC. | $184.03 | 2019-2022 | |
| Philips North America LLC | $152.04 | 2020-2023 | |
| Medtronic Vascular, INC. | $149.54 | 2019 | |
| Sanofi-Aventis U.S. LLC | $145.01 | 2019-2021 | |
| Kiniksa Pharmaceuticals International, Plc | $143.38 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, LTD. | $111.64 | 2021-2023 | Arcalyst |
| Astellas Pharma US INC | $111.49 | 2019-2022 | |
| Penumbra, INC. | $91.00 | 2019 | |
| Vifor Pharma, INC. | $89.50 | 2019 | |
| Bridgebio Pharma, INC. | $48.81 | 2025 | Attruby |
| Glaxosmithkline, LLC. | $47.38 | 2025 | Shingrix |
| Esperion Therapeutics, INC. | $44.64 | 2020 | |
| Edwards Lifesciences Corporation | $41.28 | 2020-2025 | Pascal |
| Akcea Therapeutics, INC. | $36.77 | 2020 | |
| Angiodynamics, INC. | $28.82 | 2021 | |
| Baxter Healthcare | $25.68 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Seqirus USA INC | $25.00 | 2025 | Flucelvax, Fluad |
| Daiichi Sankyo INC. | $20.94 | 2023 | Injectafer |
| Octapharma USA, INC. | $19.24 | 2025 | Balfaxar |
| Irhythm Technologies, INC. | $19.16 | 2022 | |
| Chiesi USA, INC. | $17.11 | 2022 | |
| Gilead Sciences, INC. | $14.00 | 2019 | |
| Allergan, INC. | $11.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pradeep Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.